At the beginning of the opening up, in order to attract foreign investment, many high-quality brands were sold to foreign companies. This situation was a bit overkill, and later caused a great negative impact. Changhong once attracted a large number of consumers in the name of domestic products; if It was the 1990s, and it was probably not easy for Shen Long to handle such a situation, but now it is already 2003, and many things have changed. If the amount of investment had not been so large, the district would not have been so strong. .

So he found some reporters and wanted to use their channels to let more people see the true purpose of Novavax and let some people see clearly the conspiracy behind this acquisition.

Shen Long talked about what happened between him and Novavax, and then a reporter asked, "Mr. Cheng, as far as I know, our country's pharmaceutical industry is indeed far behind foreign countries, so it might not be a good thing to accept the other party's acquisition. We You can learn a lot from it, isn’t it better than working behind closed doors?”

The saying of using the market for technology is still very popular nowadays, and some companies have indeed learned technology from it, but not every company is like this. Shen Long explained, "Nova's technology is indeed more advanced than ours, but we are not without it." Our own strengths, such as artemisinin back then, and the vitamin C production technology acquired by Roche.”

"The Chinese patent medicine we are about to produce is more effective than Novavax's Glenin, and the cost is also lower. In other words, our technology is not lagging behind in this project. If we insist on saying so, maybe The production technology is just not as good as that of Novavax, but I need to remind you again that our medicine is a Chinese patent medicine, and Novavax is good at the preparation of Western medicines. In the field of Chinese patent medicines, they are no better than us." These production lines were debugged by Shen Long himself. With Lao Bai's talent in chemistry and engineering, Shen Long would definitely do a better job than Nova.

"In addition, if Novavax cooperates with us after purchasing the patent to mass-produce this drug and then put it on the market at a lower price so that more patients can be treated, I am actually not opposed to this acquisition. ." Shen Long changed the topic, "But according to my understanding of international pharmaceutical giants, they will definitely not do this."

"Why?" The reporter didn't quite understand. According to common sense, having cheaper products on the market is a good thing for both companies and consumers.

"International pharmaceutical giants are very good at buying patents and building patent barriers to maintain their monopoly position." Shen Long spread knowledge to them, "Let me give you an example."

"In 1933, the Germans invented the 'Ley's chemical method' for producing vitamin C. This method is complex and has high production costs. Only Roche of Switzerland, BASF of Germany and Takeda Pharmaceutical of Japan have the strength to produce it in the world. These three companies have formed a Price alliance, controlling the production and price of vitamin C.”

"In the 1980s, Yin Guanglin of the Institute of Microbiology of the Chinese Academy of Sciences invented the 'two-stage preparation method', which greatly reduced the production costs and requirements of vitamin C. International pharmaceutical giants responded immediately, and Roche spent US$4 million to buy this patent. ;Then they continue to use the old methods to produce vitamin C."

"This is a defensive strategy, because cheaper technology will affect their monopoly position. They bought the patent not to use it, but to prevent other companies from obtaining the patent for production. Fortunately, when they sold it, they only sold it overseas. The right to use the patent, otherwise we would still have to spend a lot of money to buy vitamin C."

"Are you saying that Novavax has the same plan as Roche? It will buy the patent and not use it." Now the reporter understood.

"Yes, they already have a drug called Glenin to treat leukemia. Of course they will not develop the same drug again." Shen Long nodded decisively, "Are there many brands that were acquired by foreign companies in the past few years but abandoned? After Pepsi-Cola acquired Tianfu Cola, the brand disappeared; SC Johnson acquired Mega toothpaste, which once occupied 70% of the domestic market. Can you still buy this toothpaste in supermarkets now?" Shen Long also cited examples from other industries.

"This is a conspiracy of foreign capital, which is to destroy our national industry and clear the way for them to completely occupy the domestic market." At this time, some reporters were really conscientious. Immediately, a young reporter said indignantly, "Cheng Sir, you can rest assured that I will definitely expose Nova's conspiracy and let more readers know the truth of the matter."

"It needs to be reminded that the price of Novavax's Glenin is close to 40,000 yuan. How many people in the country can afford the drug cost of 40,000 yuan a month? But the Chinese patent medicine we developed only costs 100 yuan of Glenin." One percent; this is different from daily consumer products such as Coke and toothpaste. Once acquired by Nova Corporation, those patients who cannot afford 40,000 yuan a month will have no choice but to wait for death." Shen Long said in a heavy tone.

His tone once again infected the reporters. They are also human beings, and they are also worried that they will get sick. If they encounter pharmaceutical companies like this in the future, I am afraid no one can handle it.

"It is important to attract foreign investment, but we cannot ignore people's livelihood. This incident is very representative. I will write an in-depth article and publish it as soon as I get back." Reporters expressed their opinions one after another.

"Nova Corporation has great influence on the media. I estimate that once the article is published, they will definitely put pressure on you." Shen Long reminded that Nova Corporation spends a lot of money on media advertisements every year.

"There's no need to worry about this. Although I work at XX newspaper, this is not the only channel where I can publish articles. I still don't believe that Nova can buy all the media." An older reporter said confidently said.

For the media, buying them not to report a certain news is more costly than buying them to report a specific news. If you want the media not to report the news, you have to buy almost all media, but to report a certain news, you only need one media. The difference between the two The level of difficulty is different.

Novavail may be able to do so abroad, but it definitely does not have the ability to silence all media in China.

The reporters are ready to go back to write articles with full harvest. I believe that relevant news reports will appear in the media as soon as tomorrow.

Director Qiao was eye-opening. How could the matter be solved like this? By exerting pressure through the media, he must not dare to force them to accept the acquisition, right?

"Hey, Xiao Cheng, you are a bit presumptuous." Thinking back, although Shen Long's method was effective, it was not in line with conventional practice, and Director Qiao was a little worried.
Chapter completed!